227 related articles for article (PubMed ID: 24840883)
1. The large intracellular loop of ptch1 mediates the non-canonical Hedgehog pathway through cyclin B1 in nevoid basal cell carcinoma syndrome.
Yu FY; Hong YY; Qu JF; Chen F; Li TJ
Int J Mol Med; 2014 Aug; 34(2):507-12. PubMed ID: 24840883
[TBL] [Abstract][Full Text] [Related]
2. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.
Sun LS; Li XF; Li TJ
J Dent Res; 2008 Jun; 87(6):575-9. PubMed ID: 18502968
[TBL] [Abstract][Full Text] [Related]
3. PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review.
Guo YY; Zhang JY; Li XF; Luo HY; Chen F; Li TJ
PLoS One; 2013; 8(10):e77305. PubMed ID: 24204797
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation of the PTCH1 gene activates the Shh/Gli signaling pathway in a Chinese family with nevoid basal cell carcinoma syndrome.
Zhang T; Chen M; Lü Y; Xing Q; Chen W
Biochem Biophys Res Commun; 2011 Jun; 409(2):166-70. PubMed ID: 21514272
[TBL] [Abstract][Full Text] [Related]
5. Multiple keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome having distinct PTCH1 mutations: a case report.
Sasaki R; Miyashita T; Matsumoto N; Fujii K; Saito K; Ando T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):e41-6. PubMed ID: 20659694
[TBL] [Abstract][Full Text] [Related]
6. Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome.
Pastorino L; Pollio A; Pellacani G; Guarneri C; Ghiorzo P; Longo C; Bruno W; Giusti F; Bassoli S; Bianchi-Scarrà G; Ruini C; Seidenari S; Tomasi A; Ponti G
PLoS One; 2012; 7(8):e43827. PubMed ID: 22952776
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis.
Pan S; Dong Q; Sun LS; Li TJ
Clin Cancer Res; 2010 Jan; 16(2):442-50. PubMed ID: 20068110
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous PTCH1 Mutations Impact the Bone Metabolism in Patients With Nevoid Basal Cell Carcinoma Syndrome Likely by Regulating SPARC Expression.
Hong Y; Zhang J; Zhang H; Li X; Qu J; Zhai J; Zhang L; Chen F; Li T
J Bone Miner Res; 2016 Jul; 31(7):1413-28. PubMed ID: 26890308
[TBL] [Abstract][Full Text] [Related]
9. Myogenic tumors in nevoid Basal cell carcinoma syndrome.
Hettmer S; Teot LA; Kozakewich H; Werger AM; Davies KJ; Fletcher CD; Grier HE; Rodriguez-Galindo C; Wagers AJ
J Pediatr Hematol Oncol; 2015 Mar; 37(2):147-9. PubMed ID: 24517962
[TBL] [Abstract][Full Text] [Related]
10. Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors.
Qu J; Yu F; Hong Y; Guo Y; Sun L; Li X; Zhang J; Zhang H; Shi R; Chen F; Li T
Oral Oncol; 2015 Jan; 51(1):40-5. PubMed ID: 25458233
[TBL] [Abstract][Full Text] [Related]
11. [PTCH2 gene alterations in keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome].
Xu LL; Li TJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 40(1):15-8. PubMed ID: 18278130
[TBL] [Abstract][Full Text] [Related]
12. PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation?
Pan S; Li TJ
Oral Oncol; 2009 Oct; 45(10):861-5. PubMed ID: 19362041
[TBL] [Abstract][Full Text] [Related]
13. Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome.
Ponti G; Pollio A; Mignogna MD; Pellacani G; Pastorino L; Bianchi-Scarrà G; Di Gregorio C; Magnoni C; Azzoni P; Greco M; Seidenari S
Cancer Genet; 2012 Apr; 205(4):177-81. PubMed ID: 22559979
[TBL] [Abstract][Full Text] [Related]
14. Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.
Fujii K; Ohashi H; Suzuki M; Hatsuse H; Shiohama T; Uchikawa H; Miyashita T
Fam Cancer; 2013 Dec; 12(4):611-4. PubMed ID: 23479190
[TBL] [Abstract][Full Text] [Related]
15. Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation.
Rodrigues AL; Carvalho A; Cabral R; Carneiro V; Gilardi P; Duarte CP; Puente-Prieto J; Santos P; Mota-Vieira L
Genet Mol Res; 2014 Jul; 13(3):5654-63. PubMed ID: 25117323
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of keratocystic odontogenic tumors developing in nevoid basal cell carcinoma syndrome.
Suzuki M; Nagao K; Hatsuse H; Sasaki R; Saito K; Fujii K; Miyashita T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):348-53. PubMed ID: 23953420
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GLI1 gene activation by Patched1.
Rahnama F; Shimokawa T; Lauth M; Finta C; Kogerman P; Teglund S; Toftgård R; Zaphiropoulos PG
Biochem J; 2006 Feb; 394(Pt 1):19-26. PubMed ID: 16229683
[TBL] [Abstract][Full Text] [Related]
18. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
[TBL] [Abstract][Full Text] [Related]
19. Selective haploinsufficiency of longer isoforms of PTCH1 protein can cause nevoid basal cell carcinoma syndrome.
Suzuki M; Hatsuse H; Nagao K; Takayama Y; Kameyama K; Kabasawa Y; Omura K; Yoshida M; Fujii K; Miyashita T
J Hum Genet; 2012 Jul; 57(7):422-6. PubMed ID: 22572734
[TBL] [Abstract][Full Text] [Related]
20. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
Pandolfi S; Montagnani V; Lapucci A; Stecca B
Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
